Tekla Life Sciences Investors HQL

$ 14.71 0.41%

Tekla Life Sciences Investors Financial Ratios 2011-2024 | HQL

Annual Financial Ratios Tekla Life Sciences Investors

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
P/E	-	-	-	-	-	-	5.1	3.4	2.8	4.4
P/S	-	-	-	-	-	-	515.9	548.9	100.5	286.0
EV/EBITDA	-	-	-	-	-	-	2.5	1.7	1.4	4.4
PEG	-	-	-	-	-	-	-0.3	0.68	0.03	0.01
P/B	-	-	-	-	-	-	1.0	0.9	0.9	1.0
P/CF	-	-	-	-	-	-	-8.6	30.0	10.2	1.4
ROE %	-	-	-	-	-	-	20.10	28.00	34.18	21.96
ROA %	-	-	-	-	-	-	20.07	27.96	34.12	21.84
ROCE %	-	-	-	-	-	-	-	-	-	-
DSO	-	-	-	-	-	-	41.5	70.2	34.1	512.3
DIO	-	-	-	-	-	-	-	-	-	-
DPO	-	-	-	-	-	-	8.8	-	-	72.5

All numbers in USD currency